]>
IRCT20210121050095N1 IRCT 2021-05-19 Qazvin University of Medical Sciences Evaluation of the effect of bisoprolol in the control of atrial fibrillation Evaluation of the effect of oral Bisoprolol in comparison with oral Metohexall in prevention of atrial fibrillation in coronary artery bypass graft (CABG) 2020-08-26 anticipated 114 Complete https://irct.ir/trial/53948 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be assigned to two groups using a simple random method. Bisoprolol will be assigned to the first group and methohexal will be prescribed to the second group They will be, Blinding description: This study is double-blind. and researchers and patients were blind to this allocation. Doctors who also interpret electrocardiograms will be blind to the allocation of patients.After completing the study and collecting the results, the relevant codes will be provided to each patient team and the method of performing the double-blind nature of the study was such that neither the patient nor the researcher were aware of patient allocation. They were similarly packaged to avoid identification. 3 Atrial fibrillation in patients undergoing coronary artery bypass grafting. Intervention 1: Intervention. Patients received bisoprolol orally with the initial dose 2.5 mg one day before surgery to 3 days postoperatively based on heart rate, blood pressure, and ECG. Intervention 2: Control group: Patients received methohexal at an initial dose of 23.75 mg orally one day before surgery to 3 days postoperatively based on heart rate, blood pressure, and ECG. Yes - There is a plan to make this available What will be shared: After coding and unidentifiable, patients are shared based on the main consequences associated with the disease When: Start access valley one year after printing results To whom: Researchers at General Medical Universities Conditions: For scientific exploitation Where to obtain: Saeid Negahdar Hadadan/S.negahdar@qums.ac.ir How to obtain: Send an email explaining the reason for the request Comments:
public Saeid Negahdar hadadan
Gazvin minodar badar shargi
Gazvin Iran (Islamic Republic of) 3419915315 +98 28 3333 2930 S.negahdar@qums.ac.ir Qazvin University of Medical Sciences scientific Saeid Negahdar hadadan
Gazvin minodar badar shargi
Gazvin Iran (Islamic Republic of) 3419915315 +98 28 3333 2930 S.negahdar@qums.ac.ir Qazvin University of Medical Sciences Iran (Islamic Republic of) All patients with coronary heart disease are candidates for coronary heart surgery no limit no limit Both History of previous atrial fibrillation Having a permanent pacemaker Any conclusive evidence of any ventricular or supra ventricular arrhythmia Large left ventricle Moderate to severe valvular heart disease myocardial infarction Lung disease I48 Atrial fibrillation and flutter Treatment - Drugs Treatment - Drugs Intervention. Patients received bisoprolol orally with the initial dose 2.5 mg one day before surgery to 3 days postoperatively based on heart rate, blood pressure, and ECG. Control group: Patients received methohexal at an initial dose of 23.75 mg orally one day before surgery to 3 days postoperatively based on heart rate, blood pressure, and ECG. Incidence of atrial fibrillation after coronary artery surgery. Timepoint: Up to four days after coronary artery surgery. Method of measurement: How to diagnose and measure atrial fibrillation using ECG based on p's presence and irregularity of QRS and QRS count. Qazvin University of Medical Sciences Approved 2020-08-24 Ethics committee of Qazvin University of Medical Sciences No.16,badr st Eats,8th Alley Qazvin Qazvin Iran (Islamic Republic of)